Sponsors

Unveiling the sthemO haemostasis solution with unique dual technology

Stago’s new high-throughput, fully automated coagulation analyser delivers precision, speed and productivity as demonstrated in recently published studies. The company has worked in blood-based diagnostics for over 60 years, becoming a preferred commercial partner to coagulation laboratory specialists.

Stago’s innovative approach to technology and testing which it has exhibited over the past decades continues with the launch of its next generation ‘sthem’ solutions. These offer a new range of haemostasis instruments and reagents to meet, even exceed, the current needs of the NHS coagulation testing service, both routine and specialist.

Leading the way are new sthemO haemostasis analysers, the first example of which is being unveiled to the UK diagnostics community at this year’s IBMS Congress. The flagship sthemO 301 is a high-throughput, fully automated coagulation analyser for medium to large laboratories.

“Precision, accuracy, speed and productivity are the standout features of the new sthemO 301,” says Yannig Querel, Business Unit Marketing Manager - UK. “Our new random-access analyser offers continuous loading with a capacity of 168 samples - providing a walkaway capacity that elevates productivity levels.” 

Log in or register FREE to read the rest

This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text. If you don't already have an account, please register with us completely free of charge.

Latest Issues

The Power to Disrupt - Clinical Diagnostics Expo UK

15 Hatfields
16 September, 2024

Microbe Conference 2024

Crowne Plaza Hotel, Sheffield, UK
20-22 September, 2024

Cardiac Marker Dialogues: Cardiac Biomarkers in Real Time – Experiences and Opportunities

Hilton Glasgow, 1 William Street, Glasgow, Scotland, G3 8HT
26-27 September, 2024

UK NEQAS: Navigating Quality Standards in Point of Care Testing

The Hyatt Regency Hotel, Birmingham, UK
23 October, 2024